Ignite Creation Date:
2025-12-24 @ 12:31 PM
Ignite Modification Date:
2026-04-15 @ 8:08 PM
Study NCT ID:
NCT02354261
Status:
COMPLETED
Last Update Posted:
2020-08-05
First Post:
2015-01-21
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Open-label Trial of SUBA™-Itraconazole (SUBA-Cap) in Subjects With Basal Cell Carcinoma Nevus Syndrome (BCCNS)
Sponsor:
HedgePath Pharmaceuticals, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-08-07
Start Date Type:
ACTUAL
Primary Completion Date:
2019-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-03
Completion Date Type:
ACTUAL
First Submit Date:
2015-01-21
First Submit QC Date:
None
Study First Post Date:
2015-02-03
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-08-03
Last Update Post Date:
2020-08-05
Last Update Post Date Type:
ACTUAL